H Lundbeck A/S Total Assets

Latest as of December 2025: Dkr54.01 Billion DKK ≈ $8.45 Billion USD

H Lundbeck A/S total assets. Based on the latest financial reports, H Lundbeck A/S (HLUN-B) holds total assets worth Dkr54.01 Billion DKK (≈ $8.45 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see H Lundbeck A/S (HLUN-B) market capitalisation for the company's overall valuation and market capitalisation.

Total Assets of H Lundbeck A/S (2004–2025)

Total assets of H Lundbeck A/S from 2004 to 2025. This chart illustrates how H Lundbeck A/S's total assets have evolved over time, based on quarterly financial data. See current stock price of H Lundbeck A/S for real-time trading data and today's change.

H Lundbeck A/S - Asset Composition Analysis

H Lundbeck A/S Total Assets Breakdown (December 2025)

H Lundbeck A/S total assets breakdown as of December 2025. H Lundbeck A/S's total assets of Dkr54.01 Billion consist of 23.7% current assets and 76.3% non-current assets.

Asset Category	Amount (DKK)	% of Total Assets
Cash & Equivalents	Dkr0.00	6.4%
Accounts Receivable	Dkr4.55 Billion	8.4%
Inventory	Dkr4.47 Billion	8.3%
Property, Plant & Equipment	Dkr0.00	0.0%
Intangible Assets	Dkr28.77 Billion	53.3%
Goodwill	Dkr7.01 Billion	13.0%

Asset Composition Trend (2004–2025)

This chart illustrates how H Lundbeck A/S's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is H Lundbeck A/S's working capital to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: H Lundbeck A/S's current assets represent 23.7% of total assets in 2025, a decrease from 51.7% in 2004.
Cash Position: Cash and equivalents constituted 6.4% of total assets in 2025, down from 25.2% in 2004.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 65.0% of total assets, an increase from 14.0% in 2004.
Asset Diversification: The largest asset category is intangible assets at 53.3% of total assets.

H Lundbeck A/S Competitors by Total Assets

Key competitors of H Lundbeck A/S based on total assets are shown below.

Company	Country	Total Assets
GALDERMA GROUP AG NYSE:GALDY	USA	$13.39 Billion
Takeda Pharmaceutical Company Limited F:TKDA	Germany	€15.41 Trillion
Galderma Group N SW:GALD	Switzerland	CHF12.88 Billion
Enzymatica publ AB ST:ENZY	Sweden	Skr149.24 Million
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	China	CN¥13.98 Billion
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	China	CN¥17.01 Billion
Kangmei Pharmaceutical Co Ltd SHG:600518	China	CN¥13.68 Billion
Walvax BioTech SHE:300142	China	CN¥10.50 Billion

H Lundbeck A/S - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.44	1.52	1.02
Quick Ratio	0.94	1.05	0.69
Cash Ratio	0.00	0.00	0.00
Working Capital	Dkr3.93 Billion	Dkr4.43 Billion	Dkr143.00 Million

H Lundbeck A/S - Advanced Valuation Insights

This section examines the relationship between H Lundbeck A/S's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.60
Latest Market Cap to Assets Ratio	0.13
Asset Growth Rate (YoY)	-5.2%
Total Assets	Dkr54.01 Billion
Market Capitalization	$6.77 Billion USD

Valuation Analysis

Below Book Valuation: The market values H Lundbeck A/S's assets below their book value (0.13x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: H Lundbeck A/S's assets decreased by 5.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for H Lundbeck A/S (2004–2025)

The table below shows the annual total assets of H Lundbeck A/S from 2004 to 2025.

Year	Total Assets	Change
2025-12-31	Dkr54.01 Billion ≈ $8.45 Billion	-5.20%
2024-12-31	Dkr56.98 Billion ≈ $8.91 Billion	+52.31%
2023-12-31	Dkr37.41 Billion ≈ $5.85 Billion	-0.12%
2022-12-31	Dkr37.45 Billion ≈ $5.86 Billion	+8.08%
2021-12-31	Dkr34.65 Billion ≈ $5.42 Billion	-3.82%
2020-12-31	Dkr36.03 Billion ≈ $5.64 Billion	+0.76%
2019-12-31	Dkr35.76 Billion ≈ $5.59 Billion	+55.39%
2018-12-31	Dkr23.01 Billion ≈ $3.60 Billion	+16.48%
2017-12-31	Dkr19.76 Billion ≈ $3.09 Billion	-2.25%
2016-12-31	Dkr20.21 Billion ≈ $3.16 Billion	-5.23%
2015-12-31	Dkr21.32 Billion ≈ $3.34 Billion	-16.82%
2014-12-31	Dkr25.64 Billion ≈ $4.01 Billion	+8.41%
2013-12-31	Dkr23.65 Billion ≈ $3.70 Billion	+9.67%
2012-12-31	Dkr21.56 Billion ≈ $3.37 Billion	+5.01%
2011-12-31	Dkr20.53 Billion ≈ $3.21 Billion	+14.05%
2010-12-31	Dkr18.00 Billion ≈ $2.82 Billion	+5.13%
2009-12-31	Dkr17.13 Billion ≈ $2.68 Billion	+35.86%
2008-12-31	Dkr12.61 Billion ≈ $1.97 Billion	+2.28%
2007-12-31	Dkr12.33 Billion ≈ $1.93 Billion	+5.98%
2006-12-31	Dkr11.63 Billion ≈ $1.82 Billion	+0.02%
2005-12-31	Dkr11.63 Billion ≈ $1.82 Billion	+1.04%
2004-12-31	Dkr11.51 Billion ≈ $1.80 Billion	--

About H Lundbeck A/S

CO:HLUN-B Denmark Drug Manufacturers - Specialty & Generic

Market Cap

$6.77 Billion

Dkr43.27 Billion DKK

Market Cap Rank

#2836 Global

#20 in Denmark

Share Price

Dkr54.55

Change (1 day)

+0.18%

52-Week Range

Dkr36.98 - Dkr54.55

All Time High

Dkr90.49